Current and potential roles of immuno-PET/-SPECT in CAR T-cell therapy

Chimeric antigen receptor (CAR) T-cell therapies have evolved as breakthrough treatment options for the management of hematological malignancies and are also being developed as therapeutics for solid tumors. However, despite the impressive patient responses from CD19-directed CAR T-cell therapies, ~...

Descripción completa

Detalles Bibliográficos
Autores principales: Mulgaonkar, Aditi, Udayakumar, Durga, Yang, Yaxing, Harris, Shelby, Öz, Orhan K., Ramakrishnan Geethakumari, Praveen, Sun, Xiankai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333708/
https://www.ncbi.nlm.nih.gov/pubmed/37441689
http://dx.doi.org/10.3389/fmed.2023.1199146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333708/
https://www.ncbi.nlm.nih.gov/pubmed/37441689
http://dx.doi.org/10.3389/fmed.2023.1199146

Ejemplares similares